What’s the Buzz? Cannabis is currently a multi-billion-dollar industry, with the passage of the Agriculture Improvement Act of 2018 (Farm Act) portending continued explosive growth for hemp-containing products, including CBD, in the coming years. Simultaneously, the vast majority of cannabis-derived products, including CBD, are still illegal under the Federal Food, Drug, and Cosmetic Act and in some states despite seemingly ubiquitous marketing of these products. Additionally, marijuana-containing products, although legal for medical and/or adult-use in over 30 states, remain illegal under the Controlled Substances Act, creating a confusing federal/state dynamic for the burgeoning cannabis industry. 

This conference will identify uncertainties in CBD and cannabis regulation and guide attendees on how to move forward despite this uncertainty. The first day of the conference we will engage in level-setting regarding the current federal and state regulatory landscape of CBD and cannabis products. On the second day, industry experts will discuss what issues are in flux, risks and challenges for manufacturers, and what potential solutions look like for the future of regulation.

venue sponsor

This conference is designed for:

  • Industry representatives interested in manufacturing and selling cannabis-derived products, such as CBD;
  • Regulators that may have authority over cannabis-derived products; and
  • Attorneys who practice in this space.

Conference Highlights:

  • Current Federal Regulatory Landscape
  • Enforcement Trends
  • Existing FDA-Regulated Products Definitions and Applicability to Cannabis-Derived Products
  • Agriculture Improvement Act of 2018
  • Current Status of Cannabis Research and Areas for Growth
  • Safety, Product Quality, Labeling, and Marketing Considerations

Keynote Address: Sharon Mayl,Senior Advisor for Policy, Office of Food Policy and Response, FDA


Industry & Firms

  • +$250 for non-members


  • +$200 for non-members


  • +$200 for non-members


  • +$200 for non-members


  • full-time students only

To ensure that FDLI is able to provide you with a seat, materials, and meals, please register for programs at least 48 hours in advance. While onsite registration is available on a “space-available” basis; late registrants are not guaranteed materials or meals.

You can transfer your registration to another person at your organization for no cost by notifying us of the change. If you notify FDLI in writing at least five business days prior to the meeting, you can cancel your registration for a full refund (less a $75 fee). Refunds will be applied against the original form of payment.  

Our event policies are listed here. If you should have any further questions, please contact us at [email protected] or 800-956-6293.


Sponsorship opportunities are available. Please let us know if you would like more information.





Silver Sponsor



Silver Sponsor





Silver Sponsor


Planning Committee

Committee Members 

Linda Bentley, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Bridget C.E. Dooling, George Washington University
William A. Garvin, Buchanan Ingersoll & Rooney PC
Aidan Hampson, National Institutes of Health, National Inst. of Drug Abuse
Jonathan Havens, Saul Ewing Arnstein & Lehr
Larry K. Houck, Hyman, Phelps & McNamara, PC
Erika Lietzan, University of Missouri – Columbia School of Law
Brian J. Malkin, Arent Fox, LLP
Patrick Moen, Privateer Holdings
Heike Newman, University of Colorado
Jessica O’Connell, Covington & Burling LLP
Christopher G. Van Gundy, Sheppard Mullin Richter & Hampton LLP